Facebook Linkedin Twitter
Inside Precision Medicine Pembrolizumab Trial in Advanced Melanoma Shows Major Pathological Response Exceeding 50%

Skin cancer

Melanoma Tissue
News & Features

Pembrolizumab Trial in Advanced Melanoma Shows Major Pathological Response Exceeding 50%

Chris Anderson -
0
Skin cancer, light micrograph
News & Features

MEK Inhibitor Sparks Hope as Novel Treatment for Common Skin Cancer

Alisa Kirkin -
0
Invasive Squamous Cell Carcinoma, skin cancer, on Left Arm
News & Features

Non-Melanoma Skin Cancer Kills More People Than Melanoma

Chris Anderson -
0
Glioblastoma brain cancer, CT scan
News & Features

Why Glioblastoma Does Not Respond to Immunotherapy, But Other Brain Cancers Do

Malorye Branca -
0
Melanoma cancer cells of human under microscope
Oncology

Combination Immunotherapy Effective for Second-Line Melanoma Treatment

Chris Anderson -
0
Close up of melanoma
News & Features

Chronic Angina Drug Improves Melanoma Treatment Efficacy in Mouse Model

Chris Anderson -
0
Woman cancer patient
News & Features

Are We Nearly There Yet?

Kathy Vuksanaj -
0
Oncologist Discussing Medications with a Senior Patient
News & Features

Second Cancer Survival Lower in Black and Hispanic People than White

Helen Albert -
0
3D virus cells attacking a DNA strand
News & Features

Merkel Cell Carcinoma Virus Hijacks Host Cell Replication

Chris Anderson -
0
3D structure of a melanoma cell derived by ion abrasion scanning electron microscopy.
News & Features

New Immunotherapy Biomarkers for Melanoma Uncovered

Malorye Branca -
2
1234...15Page 3 of 15

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine